References

SCIENTIFIC PAPERS

There are over 4000 articles on Ketamine for depression, most of them published in the past 5 years.The following are representative of this enlarging body of evidence:

Ketamine and Depression – A Narrative Review

Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics

BOOKS

The Ketamine Papers: Science, Therapy and Transformation
Edited by Phil Wolfson, MD and Glen Hartelius, Ph.D.

How to Change Your Mind
By Michael Pollan

Ketamine (The MIT Press Essential Knowledge series)
by Bita Moghaddam (Author)

VIDEOS

The Psychology of Psychedelics: Dr Roland Griffiths, Ph.D.
978,000 views May 10, 2021 The Dr Jordan B Peterson Podcast

Dr. Roland Griffiths, Ph.D., is a professor of neuroscience, psychiatry, and behavioral science and director of the Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine. He is the author of over 400 scientific research publications.

Ketamine Therapy for Treatment resistant Depression

Ketamine Assisted psychotherapy with Dr Katy Daly

Does Ketamine Live up to the Hype of Depression?

Psychedelics: Chemicals, Consciousness and Creativity

FOR MORE INFORMATION ABOUT THE CENTER FOR PSYCHEDELIC AND CONSCIOUSNESS RESEARCH:

The Johns Hopkins University Psychedelics Department, first in the country, teaching the science of psychedelics.

The Multidisciplinary Association for Psychedelic Studies

Currently conducting Phase 3 clinical trials of MDMA and psylocibin for PTSD and depression. Because of their work, these medicines will soon be available for clinical use, possibly as soon as 2023.